Právní předpis byl sestaven k datu 22.02.2023.
Zobrazené znění právního předpisu je účinné od 22.02.2023.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2023
41/2023 Sb.
41
SDĚLENÍ
Ministerstva xxxxxxxxxxxxx
xx xxx 10. xxxxx 2023
o xxxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2023
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. e) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx a o xxxxx některých xxxxxxxxxxxxx xxxxxx, xx znění xxxxxxxxxx xxxxxxxx, xxxxxxx xx xxxxxxx xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx xxx xxx 2023:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx xxxxx), tetanu, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), virové xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 mezinárodních xxxxxxxx (XX)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx Xxxxxxxxxxx (PRN)1 8 xxxxxxxxxx
Xxxxxxxxx tegiminis xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis xxxxxxxxxxx (XXX)
xxxxx 1 (xxxx Xxxxxxx)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Saukett)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx influenzae xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. cum xxxxxx. tetanico xxxx xxxxx xxxxxxx přibližně 25 xxxxxxxxxx
1 adsorbováno xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Al3+
2 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx xx xxxxxxx xxxxxxxxxxxx xxxxx Saccharomyces xxxxxxxxxx)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx xx VERO buňkách
NEBO
1aa) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX)2
Xxxxxx xxxxxxxxxx ne xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (IU)2
Antigeny Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 mikrogramů
Haemagglutinum xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Poliomyelitidis (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 D jednotek xxxxxxxx4
xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx hepatitidis X5 10 xxxxxxxxxx
Xxxxxxxxxxxxxxxxxxx xxxxxxxx xxxxxxxxxx influenzae X 12 mikrogramů
(Polyribosylribitoli xxxxxxxx)
xxxxxxxxx xxx xxxxxx xxxxxxxxxx 22-36 xxxxxxxxxx
1 xxxxxxxxxxx xx hydratovaný xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 xxxx xxxxxx xxx spolehlivosti (x = 0,95)
3 xxxxxxxxx xx VERO xxxxxxx
4 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx imunochemickou xxxxxxx
5 xxxxxxxx rekombinantní XXX xxxxxxxxxxx x kvasinkových xxxxxxx Xxxxxxxxx polymorpha
NEBO
1ab) Xxxxxxx xxxxx záškrtu, xxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx komponenta), xxxxxxxxxx X (xXXX), xxxxxx xxxxxxxx obrně (inaktivovaná) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (xxxxxxxxxxx)
Xxxxx dávka (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 IU
Tetani xxxxxxxxxx1 xx xxxx xxx 40 XX
Xxxxxxxx Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (inactivatum)4
Typus 1 (Xxxxxxx) 40 X xxxxxxxx antigenu5
Typus 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx typus x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx conjunctum cum xxxxxxxxx xxxxxxxxxxxx xxxxx x2 50 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 xx Xx3+)
2 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 mg Xx3+)
3 xxxxxxxx rekombinantní XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 pomnoženo xx Xxxx xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx antigenu xxxxxxxxx xxxxxxx imunochemickou xxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx (DTaP)
Jedna dávka (0,5 xx) xxxxxxxx xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 mikrogramů
Pertussis xxxxxxxxxxxxxxx xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69 xX) 8 mikrogramů
* xxxxxxxxxxx xx hydroxid xxxxxxx xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx záškrtu, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Xxxxxxxxx 20 XX* (5 Lf)
Pertusové xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 mikrogramy
Fimbriae, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 mg xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx a dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx) xx sníženým xxxxxxx xxxxxxxx (Xxxx)
Xxxxx dávka (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 2 mezinárodní xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 xxxxxxxxxxxxx jednotek (XX) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 adsorbováno xx xxxxxxxxxxx hydroxid xxxxxxx (Xx(XX)3) 0,3 miligramů Xx3+ x xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b:
Jedna xxxxx xxxxxxxxxxxxx xxxxxxx obsahuje:
Polysaccharidum Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Anatoxino xxxxxxxx (přibližně 25 xxxxxxxxxx).
1x) očkovací xxxxx xxxxx tetanu:
Jedna dávka xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X v dětské xxxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 10 mikrogramů
1f) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X x xxxxxxx formuli
Jedna xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx a zarděnkám:
Jedna xxxxx xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) min. 103,0 infekční dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxx virus xxxxxxxxxx2 (Wistar RA 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx kuřecích xxxxxx
2 pomnoženo xx xxxxxxxx xxxxxxxxxxx xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) xx xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 vivum attenuatum (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 vivum xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % xxxxxxxx dávka xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx kuřecích xxxxxx.
2 xxxxxxxx xx lidských xxxxxxxxxxx plicních XX-38 xxxxxxxxxxxxx.
1x) očkovací látka xxxxx xxxxxx přenosné xxxxx v inaktivované xxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 1 (Xxxxxxx).....40 antigenních X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 2 (XXX-1) ..........8 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3 (Xxxxxxx)........32 xxxxxxxxxxx X xxxxxxxx*
* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxx xxxxxx xxxxxxxxxxxxx xxxxxx.
1xx) očkovací xxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxxxxx xxxxxxxx:
1xxx) xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 11 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µg
Streptococci pneumoniae xxxxxxxxxxxxxxx sérotypus 6A1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 7X1 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx sérotypus 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 141 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx sérotypus 18X1 2,2 µg
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23F1 2,2 µx
1 Xxxxxxxxxx x xxxxxx xxxxxxxxx XXX197 x adsorbován xx xxxxxxxxxxx xxxxxxx (0,125 mg xxxxxxx).
1xxx) xxxxxxxxxxxxxxx xxxxxxxx xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6B, 7X, 8, 9N, 9X, 10X, 11A, 12F, 14, 15X, 17X, 18X, 19F, 19X, 20, 22X, 23F, 33X.
1x) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - xx xxxx xxx 2 xxxxxxxxxxx jednotky (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx haemagglutinum xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Mahoney)2 - 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)2 - 8 X jednotek antigenu
typus 3 (xxxx Saukett)2 - 32 X xxxxxxxx xxxxxxxx
1 Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Al3+ x xxxxxxxxxxx hlinitý (XxXX4) 0,2 xxxxxxxxx Al3+
2 xxxxxxxxx na XXXX xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx minimálně 2 XX* (2,5 Xx)
Xxxxxx xxxxxxxxxx minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X xxxxxxxx xxxxxxxx
xxxxx 2 8 X xxxxxxxx antigenu
typus 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx xxxxxxx 1,5 mg (0,33 mg xxxxxxx)
* Xxxx spodní hranice xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xxx xxxxx xxxxxxxx do xxxxxxxxxxxx xxxxxxxx:
Xxxxx dávka (0,5 xx) vakcíny xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 xxxxxxxxxx
1 xxxxxxxxxx na XX04X xxxxxxxxxx: - 3-0-xxxxxx-4'-xxxxxxxxxxxx-xxxxx A (MPL)2 50 mikrogramů
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx na xxxxxxx kvasinkových xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) xxxxxxxxxxxxx XXX technologií.
2. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx hepatitidě X xx xxxxxxx xxx xxxxxxx:
Xxxxx dávka obsahuje:
Antigenum xxxxxxxxx xxxxxxxxxxx B - 20 mikrogramů
2b) xxxxxxxx xxxxx proti xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X ve xxxxxxx xxx dospělé:
Jedna dávka xxxxxxxx:
Xxxxxxxxx X virus xxxxxxxxxxx
2x) xxxxxxxx látka xxxxx spalničkám, příušnicím x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) min. 103,0 xxxxxxxx xxxxx pro xxxxxxxx kulturu503
Parotitidis virus xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx pro buněčnou xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3 50% infekční xxxxx xxxxxxx kultury
NEBO
2da) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Edmonston) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Lynn™, hladina X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx attenuatum (xxxx Xxxxxx RA 27/3) xx xxxx xxx 1x103 CCID50*
* 50 % xxxxxxxx xxxxx xxxxxxx kultury
1 xxxxxxxx xx xxxxxxx xxxxxxxx embryí.
2 vyrobeno xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxx xxxxxxxx
3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx xxxxxxx:
Xxxxx hepatitis X xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A ve xxxxxxx xxx xxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x) xxxxxxxx látka proti xxxxxxxxxx, příušnicím a xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou kulturu503
1 xxxxxxxxx na buňkách xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x zarděnkám
Po xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx attenuatum (xxxx Xxxxxx’ Edmonston) xx xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 CCID503
Virus rubeolae2 xxxxx attenuatum (kmen Xxxxxx XX 27/3) xx xxxx než 1x1103 CCID503
* 50% xxxxxxxx dávka tkáňové xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 41/2023 Xx. xxxxx xxxxxxxxx xxxx 22.2.2023.
Xx xxx xxxxxxxx xxxxxx xxxxxxx nebyl xxxxx xx xxxxxxxxx.
Xxxxx jednotlivých xxxxxxxx xxxxx xxxxxx xxxxxxxx předpisů v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx jich xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.